3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1
1
Status
Active not recruiting
23
Recruiting
13
Completed
8
Terminated
2
Withdrawn
1
Not yet recruiting
1
Sponsor Class
NETWORK
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
2
Neoplasms
1
Neoplasm Metastasis
1
Interventions
pembrolizumab
117
Carboplatin
47
Nivolumab
46
Paclitaxel
34
Cyclophosphamide
34
Cisplatin
33
Gemcitabine
30
atezolizumab
27
Specimen Handling
26
Magnetic Resonance Spectroscopy
25
venetoclax
24
Docetaxel
24
fludarabine
23
Pemetrexed
23
Biopsy
22
Bevacizumab
22
Radiotherapy
21
Ipilimumab
21
Azacitidine
20
Dexamethasone
19
Radiosurgery
18
durvalumab
17
Fluorouracil
17
Cetuximab
16
Trastuzumab
15
fludarabine phosphate
14
Leucovorin
14
Cytarabine
14
tislelizumab
13
Lenalidomide
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
Ado-Trastuzumab Emtansine
×
1 year
×
Clear all
NCT04740918
2025-08-08
KATE3
Hoffmann-La Roche
Phase 3
Terminated
96 enrolled
16 charts
NCT04042051
2025-07-22
Panthera
Cancer Trials Ireland
Phase 1
Terminated
2 enrolled